Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire

Table 2 Frequency of metabolic risk factors in psoriatic patients and control group

Parameters	Psoriatic patients n = 41		Control group n = 41		χ ²	p values
Parameters	n	%	n	%	χ ²	p values
WC (≥102 cm)	27	65.9	21	51.2	1.26	0.262
SBP/DBP (≥130/85 mmHg)	17	41.5	7	17.1	4.77	0.029
Triglycerides (≥150 mg/dl)	17	41.5	16	39.0	0.00	1.000
HDL cholesterol (≤40 mg/dl)	16	39.0	10	24.4	1.41	0.235
Fasting glucose (≥100 mg/dl)	26	63.4	13	31.7	7.04	0.008
MetS diagnosis	17	41.1	9	22.0	2.76	0.097

The psoriatic patients exhibited statistically significant differences compared with controls for systolic and diastolic blood pressure and fasting glucose. According to the NCEP ATP III definition, the metabolic syndrome is defined as the coexistence of three or more of the following findings: (1) Increased waist circumference. (2) Hypertriglyceridaemia. (3) Hypertension. (4) Elevated fasting plasma glucose. (5) Low high-density lipoprotein (HDL) cholesterol level. Results are expressed as number and percentage. The Chi square (χ ²) test was used to test the significance of differences between the two groups. Italicized p-values represent significant differences at p < 0.05
WC Waist Circumference, SBP systolic blood pressure, DBP diastolic blood pressure, HDL High-density lipoprotein, MetS Metabolic Syndrome

ISSN: 1479-5876